BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Digital Asset Technologies Inc. Announces Intention to Amend and Refile Financial Statements and MD&A
Digital Asset Technologies Inc. Clarifying News Release
Crypto News: AlphaPepe Announces $800k Raised While Bitcoin Price Prediction Targets $80K Breakout After Global Ceasefire
Bunker Hill Announces Equity Compensation Grants
